Beyond Animal Testing: The FDA Modernization Act and the Future of Drug Discovery

What if the biggest barrier to faster, safer drug development isn't a lack of technology, but a decades-old reliance on the wrong models? In this episode of CrownCast, host Michelle Dawn Mooney sits down with Prof. Thomas Hartung, member of Crown Bioscience's Scientific Advisory Board and Director of the Johns Hopkins Center for Alternatives to Animal Testing, to unpack how the FDA Modernization Act, AI, and next-generation in vitro systems are transforming drug discovery. Watch or listen to the full conversation below.